BusinessAbeona Therapeutics Reports Q4 2016 Financial Results and Business HighlightsBy Nasdaq OMXMar 31, 2017, 12:05 PM UTC
BusinessAbeona Therapeutics Receives Orphan Drug Designation in the European Union for EB-101 Gene Therapy Clinical Trial for Epidermolysis BullosaBy Nasdaq OMXMar 8, 2017, 1:15 PM UTC
